The inflammatory index and cytokines are associated with non-alcoholic fatty liver disease in type 2 diabetes mellitus.

ABSTRACT:

Background

Non-alcoholic fatty liver disease (NAFLD), which is characterized by hepatic steatosis in the absence of excessive alcohol consumption, is now increasingly recognized as a significant crucial factor contributing to chronic diseases, including diabetes. Moreover, it may progress to advanced hepatic pathologies such as fibrosis, cirrhosis, and even liver cancer. Systemic inflammation could be a potential mediator in the pathogenesis of diabetes secondary to NAFLD. Thus, we aim to evaluate inflammatory biomarkers to delineate their prognostic utility.

Methods

A retrospective analysis was conducted on the clinical data of 624 participants from Tianjin Third Central Hospital, spanning from January 2023 to December 2024. Among them, 234 patients with NAFLD and type 2 di

SUBMITTER: Liu R 

PROVIDER: S-EPMC12685878 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature